BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15925732)

  • 1. Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives.
    Glazer NL; Smith NL; Heckbert SR; Doggen CJ; Lemaitre RN; Psaty BM
    Am J Hypertens; 2005 Jun; 18(6):759-66. PubMed ID: 15925732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry study.
    Yoon YE; Rivera JJ; Kwon DA; Chae IH; Jeong MH; Rha SW; Blumenthal RS; Nasir K; Chang HJ;
    Prev Cardiol; 2009; 12(2):109-13. PubMed ID: 19476585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classical risk factors for myocardial infarction and total mortality in the community--13-year follow-up of the MONICA Augsburg cohort study].
    Heidrich J; Wellmann J; Hense HW; Siebert E; Liese AD; Löwel H; Keil U
    Z Kardiol; 2003 Jun; 92(6):445-54. PubMed ID: 12819993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
    Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H
    Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication for hypercholesterolemia and the risk of nonfatal acute myocardial infarction: case-control study in Japan.
    Circ J; 2002 May; 66(5):463-8. PubMed ID: 12030341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
    Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
    Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of women's coronary heart disease and risk factors prior to first myocardial infarction.
    Yawn BP; Wollan PC; Jacobsen SJ; Fryer GE; Roger VL
    J Womens Health (Larchmt); 2004 Dec; 13(10):1087-100. PubMed ID: 15650342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Achievement of the therapeutic goals for dyslipidemia in clinical practice: results of a survey among general practice physicians from Lombardy].
    Tragni E; Catapano AL; Bertelli A; Poli A
    Ital Heart J; 2003 Dec; 4 Suppl 7():47S-57S. PubMed ID: 14983746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective management of patients with dyslipidemia.
    Lipsy RJ
    Am J Manag Care; 2003 Feb; 9(2 Suppl):S39-58. PubMed ID: 12597240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study.
    Nicklas BJ; Penninx BW; Cesari M; Kritchevsky SB; Newman AB; Kanaya AM; Pahor M; Jingzhong D; Harris TB;
    Am J Epidemiol; 2004 Oct; 160(8):741-9. PubMed ID: 15466496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
    Davidson MH; Maki KC; Pearson TA; Pasternak RC; Deedwania PC; McKenney JM; Fonarow GC; Maron DJ; Ansell BJ; Clark LT; Ballantyne CM
    Am J Cardiol; 2005 Aug; 96(4):556-63. PubMed ID: 16098311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.
    Clearfield M; Downs JR; Lee M; Langendorfer A; McConathy W; Gotto AM
    Am J Cardiol; 2005 Dec; 96(12):1674-80. PubMed ID: 16360356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of total cholesterol levels on long-term mortality in coronary heart disease: a reappraisal.
    Gupta R; Singh AK; Basira R; Gupta N; Kanodia A; Gupta KD
    Indian Heart J; 2000; 52(1):23-8. PubMed ID: 10820929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
    Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
    Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.